Other studies have determined the efficacy of either anti-SLAMF7 CAR-T cell or its dual form (SLAMF7/BCMA CAR) [124] along with its combination with other anti-MM drugs, such as daratumumab and lenalidomide [54, 133]. The gene discussed is SLAMF7; the disease is Miyoshi myopathy.